The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | A | Alimentary tract and metabolism | |
| 2 | A02 | Drugs for acid related disorders | |
| 3 | A02B | DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) | |
| 4 | A02BB | Prostaglandins |
| Code | Title | |
|---|---|---|
| A02BB01 | Misoprostol | |
| A02BB02 | Enprostil |
| Active Ingredient | Description | |
|---|---|---|
| Misoprostol |
Misoprostol is an analogue of naturally occurring prostaglandin E1 which promotes peptic ulcer healing and symptomatic relief. Misoprostol protects the gastroduodenal mucosa by inhibiting basal, stimulated and nocturnal acid secretion and by reducing the volume of gastric secretions, the proteolytic activity of the gastric fluid, and increasing bicarbonate and mucus secretion. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| CYTOTEC Tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
